0001655759-24-000098.txt : 20240618 0001655759-24-000098.hdr.sgml : 20240618 20240618175330 ACCESSION NUMBER: 0001655759-24-000098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240617 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cacace Angela M CENTRAL INDEX KEY: 0002026306 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38672 FILM NUMBER: 241053338 MAIL ADDRESS: STREET 1: C/O ARVINAS, INC. STREET 2: 5 SCIENCE PARK, 395 WINCHESTER AVE. CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARVINAS, INC. CENTRAL INDEX KEY: 0001655759 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472566120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-535-1456 MAIL ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS INC. DATE OF NAME CHANGE: 20181001 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC DATE OF NAME CHANGE: 20151015 4 1 wk-form4_1718747603.xml FORM 4 X0508 4 2024-06-17 0 0001655759 ARVINAS, INC. ARVN 0002026306 Cacace Angela M C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE. NEW HAVEN CT 06511 0 1 0 0 Chief Scientific Officer 0 Common Stock 2024-06-17 4 A 0 15995 0 A 51852 D Stock Option (right to buy) 24.94 2024-06-17 4 A 0 24632 0 A 2034-06-16 Common Stock 24632 24632 D The restricted stock units (each, an "RSU") were granted by the issuer on June 17, 2024, pursuant to its 2018 Stock Incentive Plan (the "Plan") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on June 17, 2025, with the remainder of the shares vesting on June 17, 2026. The option was granted by the Issuer on June 17, 2024, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on June 17, 2025, with the remainder of the shares vesting on June 17, 2026. /s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace 2024-06-18